SOUTH SAN FRANCISCO, Calif., Oct. 29, 2013 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) (Five Prime), a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, will report its third quarter 2013 financial results on Tuesday, November 12, 2013, after the U.S. financial markets close. Five Prime will host a conference call and live audio webcast on Tuesday, November 12, 2013 at 5:00 p.m. (ET)/2:00 p.m. (PT) to discuss the company’s financial results and provide a general business update.
Help employers find you! Check out all the jobs and post your resume.
